Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
Opioids |
% inj |
Cocaine |
% inj |
Amphet- |
% inj |
Ecstasy |
Hallucin- |
% inj |
Cannabis |
Others | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Belgium |
(1) |
21.0 |
7.0 |
5.0 |
5.0 |
14.0 |
3.0 |
3.0 |
1.0 |
0.0 |
44.0 |
12.0 |
Czech Republic |
|
15.4 |
81.7 |
0.3 |
7.7 |
58.4 |
81.8 |
0.6 |
0.3 |
0.0 |
21.6 |
3.4 |
Denmark |
|
23.7 |
15.0 |
8.3 |
1.7 |
12.0 |
1.3 |
2.2 |
0.0 |
|
46.6 |
7.2 |
Germany |
(2) |
23.1 |
|
6.8 |
|
9.4 |
|
|
0.4 |
|
56.4 |
3.9 |
Greece |
|
84.5 |
46.1 |
2.7 |
5.2 |
0.1 |
0.0 |
0.4 |
0.1 |
0.0 |
10.5 |
1.7 |
Spain |
(3) |
28.0 |
20.0 |
42.0 |
6.0 |
1.0 |
6.0 |
2.0 |
0.1 |
9.0 |
23.0 |
3.9 |
France |
(4) |
50.3 |
|
6.9 |
|
0.3 |
|
1.8 |
0.3 |
|
35.9 |
4.5 |
Ireland |
(5) |
36.5 |
46.7 |
7.2 |
2.5 |
1.0 |
4.5 |
7.0 |
0.0 |
|
45.1 |
3.2 |
Italy |
|
52.9 |
55.0 |
16.5 |
6.0 |
0.1 |
0.0 |
0.9 |
0.1 |
0.0 |
23.8 |
5.7 |
Cyprus |
|
49.6 |
70.5 |
11.9 |
0.0 |
0.0 |
|
5.3 |
0.4 |
0.0 |
32.3 |
0.5 |
Latvia |
(6) |
28.4 |
|
1.1 |
|
24.5 |
|
0.7 |
1.6 |
|
19.7 |
24.0 |
Lithuania |
(7) |
79.0 |
|
0.0 |
|
2.0 |
|
|
0.0 |
|
1.0 |
18.0 |
Luxembourg |
(8) |
|
|
|
|
|
|
|
|
|
|
|
Hungary |
(9) |
6.5 |
65.9 |
0.9 |
16.0 |
4.4 |
13.8 |
3.6 |
0.5 |
0.0 |
49.4 |
34.7 |
Malta |
|
81.6 |
63.9 |
11.6 |
|
0.7 |
|
4.8 |
0.0 |
|
0.8 |
0.5 |
Netherlands |
|
11.1 |
13.1 |
36.6 |
0.5 |
6.0 |
1.9 |
1.8 |
1.4 |
3.0 |
38.2 |
4.9 |
Austria |
(10) |
100.0 |
100.0 |
0.0 |
|
0.0 |
|
0.0 |
0.0 |
|
0.0 |
0.0 |
Poland |
(11) |
19.8 |
|
1.2 |
|
11.9 |
|
|
0.8 |
|
4.4 |
61.9 |
Portugal |
(12) |
50.3 |
|
7.1 |
|
0.0 |
|
0.5 |
0.1 |
|
11.7 |
28.3 |
Slovenia |
(13) |
77.6 |
64.2 |
1.1 |
16.7 |
0.2 |
0.0 |
1.0 |
0.0 |
|
19.6 |
0.5 |
Slovakia |
|
28.3 |
69.6 |
0.6 |
33.3 |
31.6 |
34.2 |
0.4 |
1.3 |
7.1 |
25.2 |
12.6 |
Finland |
|
17.8 |
73.8 |
0.0 |
|
29.4 |
69.3 |
1.1 |
0.1 |
0.0 |
42.0 |
9.6 |
Sweden |
|
20.2 |
26.1 |
3.7 |
0.0 |
27.7 |
40.4 |
0.8 |
0.1 |
|
31.4 |
16.1 |
United Kingdom |
(13) |
58.0 |
44.0 |
12.0 |
4.0 |
5.0 |
27.0 |
2.0 |
0.1 |
6.0 |
18.0 |
4.9 |
Bulgaria |
|
90.6 |
68.2 |
0.1 |
0.0 |
1.1 |
0.0 |
0.3 |
0.0 |
|
6.9 |
2.1 |
Romania |
|
53.8 |
91.9 |
0.3 |
0.0 |
0.4 |
0.0 |
1.0 |
0.1 |
0.0 |
3.2 |
41.2 |
Turkey |
|
32.5 |
14.7 |
7.0 |
0.2 |
0.0 |
|
7.5 |
0.0 |
|
29.2 |
23.8 |
Notes: Data were not available for: Estonia, Norway, Turkey. When proportion of clients by main drug is 0, % of injectors is blank. (1) Last data available refer to 1999. (2) Data on amphetamines include amphetamines and ecstasy. Data on injection not available. Data taken from ST.04. (3) Last data available refer to 2002. (4) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003. (5) Last data available refer to 2003. (6) No data on injecting rates for 2004. (7) No information on injecting rates for 2004. Amphetamines rates refer to stimulants in general. (8) Data on first treatment were not reported in 2004 as the figures were too small. (9) Data on substance of abuse and injecting behaviours are not available. For 2004 data include injecting behaviours. (10) Data refer to clients in substitution treatment only; figures for opioids as main drug and injecting use are 100 %. (11) Last data available refer to 2003. Amphetamines refer to amphetamines and ecstasy (12) No data on injection available for 2004. Cocaine includes cocaine and freebase. Rate for 'others' includes cocaine and heroin. (13) Data relate to the period from 1 April 2003 to 31 March 2004 for UK. The percentages of new clients by main drug is more than 100 %. See also 'General notes for interpreting data' on the Explanatory notes and help page. Sources: 2005 Reitox national reports - Standard Table 3 (see Table TDI-1 for details on sources) | ||||||||||||